Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure

Mutagenesis

Volumn 27, Issue 4, 2012, Pages 423-429

  Scesnaite, Asta ^a,b   Jarmalaite, Sonata ^a,b   Mutanen, Pertti ^b   Anttila, Sisko ^b,c   Nyberg, Fredrik ^d,e   Benhamou, Simone ^f,g   Boffetta, Paolo ^h,i   Husgafvel Pursiainen, Kirsti ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f FONDATION JEAN DAUSSET CEPH   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DAPK1 GENE; DNA METHYLATION; EXPOSURE; FEMALE; GENDER; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MGMT GENE; P16 GENE; PASSIVE SMOKING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RARB GENE; RASSF1 GENE; SMOKING; SQUAMOUS CELL CARCINOMA; TP53 GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; TOBACCO; TOBACCO SMOKE POLLUTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

NICOTIANA TABACUM;

EID: 84863452360     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger092     Document Type: Article

References (42)

1. American Cancer Society (2009) Cancer Facts & Figures 2009. American Cancer Society, Atlanta, GA, USA.
2. World Health Organization (2008) World Health Statistics 2008. http://www.who.int/whosis/whostat/EN-WHS08-Full.pdf (accessed December 8, 2011).
3. International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 83. International Agency for Research on Cancer, Lyon, France, 2004. p. 1452.
4. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E. and Doll, R. (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ, 321, 323-329. (Pubitemid 30496873)
5. U.S. Department of Health and Human Services (2006) The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Atlanta, GA, USA.
6. Thun, M. J., Henley, S. J., Burns, D., Jemal, A., Shanks, T. G. and Calle, E. E. (2006) Lung cancer death rates in lifelong nonsmokers. J. Natl Cancer. Inst., 98, 691-699. (Pubitemid 43832505)
7. Husgafvel-Pursiainen, K. (2004) Genotoxicity of environmental tobacco smoke: a review. Mutat. Res., 567, 427-445.
8. Secretan, B., Straif, K., Baan, R. et al. (2009) A review of human carcinogens - part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol., 10, 1033-1034.
9. Belinsky, S. A. (2004) Gene-promoter hypermethylation as a biomarker in lung cancer. Nat. Rev. Cancer, 4, 707-717.
10. Belinsky, S. A., Liechty, K. C., Gentry, F. D. et al. (2006) Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res., 66, 3338-3344.
11. Heller, G., Zielinski, C. C. and Zöchbauer-Müller, S. (2010) Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev., 29, 95-107.
12. Belinsky, S. A., Klinge, D. M., Dekker, J. D. et al. (2005) Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin. Cancer Res., 11, 6505-6511. (Pubitemid 41338988)
13. Sun, S., Schiller, J. H. and Gazdar, A. F. (2007) Lung cancer in never smokers - a different disease. Nat. Rev. Cancer, 7, 778-790. (Pubitemid 47463669)
14. Subramanian, J. and Govindan, R. (2008) Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol., 9, 676-682. (Pubitemid 351878053)
15. Wakelee, H. A., Chang, E. T., Gomez, S. L. et al. (2007) Lung cancer incidence in never smokers. J. Clin. Oncol., 25, 472-478. (Pubitemid 350002951)
16. Boffetta, P., Agudo, A., Ahrens, W. et al. (1998) Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J. Natl Cancer Inst., 90, 1440-1450. (Pubitemid 28482008)
17. Husgafvel-Pursiainen, K., Boffetta, P., Kannio, A., Nyberg, F., Pershagen, G., Mukeria, A., Constantinescu, V., Fortes, C. and Benhamou, S. (2000) p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res., 60, 2906-2911. (Pubitemid 30395814)
18. Husgafvel-Pursiainen, K., Karjalainen, A., Kannio, A., Anttila, S., Partanen, T., Ojajärvi, A. and Vainio, H. (1999) Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations. Am. J. Respir. Cell Mol. Biol., 20, 667-674. (Pubitemid 129495785)
19. Jarmalaite, S., Kannio, A., Anttila, S., Lazutka, J. R. and Husgafvel-Pursiainen, K. (2003) Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int. J. Cancer, 106, 913-918. (Pubitemid 37071670)
20. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D. and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. U. S. A., 93, 9821-9826. (Pubitemid 26296693)
21. Virmani, A. K., Rathi, A., Zöchbauer-Müller, S. et al. (2000) Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J. Natl Cancer Inst., 92, 1303-1307. (Pubitemid 30660589)
22. Burbee, D. G., Forgacs, E. and Zöchbauer-Müller, S. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl Cancer Inst., 93, 691-699. (Pubitemid 32492810)
23. Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B. and Herman, J. G. (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res., 59, 793-797. (Pubitemid 29086728)
24. Katzenellenbogen, R. A., Baylin, S. B. and Herman, J. G. (1999) Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 93, 4347-4353. (Pubitemid 29279278)
25. Toyooka, S., Maruyama, R., Toyooka, K. O. et al. (2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer, 103, 153-160. (Pubitemid 35461506)
26. Toyooka, S., Tokumo, M., Shigematsu, H. et al. (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res., 66, 1371-1375. (Pubitemid 43259916)
27. Liu, Y., Lan, Q., Siegfried, J. M., Luketich, J. D. and Keohavong, P. (2006) Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Neoplasia, 8, 46-51.
28. Pulling, L. C., Divine, K. K., Klinge, D. M., Gilliland, F. D., Kang, T., Schwartz, A. G., Bocklage, T. J. and Belinsky, S. A. (2003) Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Cancer Res., 63, 4842-4848. (Pubitemid 37022615)
29. Divine, K. K., Pulling, L. C., Marron-Terada, P. G. et al. (2005) Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int. J. Cancer, 114, 400-405. (Pubitemid 40279960)
30. Sanchez-Cespedes, M., Decker, P. A., Doffek, K. M. et al. (2001) Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res., 61, 2092-2096. (Pubitemid 32692032)
31. Liu, Y., Gao, W., Siegfried, J. M., Weissfeld, J. L., Luketich, J. D. and Keohavong, P. (2007) Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. BMC Cancer, 7, 74.
32. Wu, J. Y., Wang, J., Lai, J. C., Cheng, Y. W., Yeh, K. T., Wu, T. C., Chen, C. Y. and Lee, H. (2008) Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Ann. Surg. Oncol., 15, 3272-3277.
33. Kim, D. H., Nelson, H. H., Wiencke, J. K., Zheng, S., Christiani, D. C., Wain, J. C., Mark, E. J. and Kelsey, K. T. (2001) p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res., 61, 3419-3424. (Pubitemid 32695035)
34. Toyooka, S., Suzuki, M., Maruyama, R. et al. (2004) The relationship between aberrant methylation and survival in non-small-cell lung cancers. Br. J. Cancer, 91, 771-774. (Pubitemid 39141639)
35. Baryshnikova, E., Destro, A., Infante, M. V. et al. (2008) Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin. Cancer Res., 14, 1913-1919. (Pubitemid 351469479)
36. Cirincione, R., Lintas, C., Conte, D., Mariani, L., Roz, L., Vignola, A. M., Pastorino, U. and Sozzi, G. (2006) Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study. Int. J. Cancer, 118, 1248-1253. (Pubitemid 43185613)
37. Destro, A., Bianchi, P., Alloisio, M. et al. (2004) K-ras and p16(INK4A) alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers. Lung Cancer, 44, 23-32. (Pubitemid 38317259)
38. Kersting, M., Fried, C., Kraus, A., Behn, M., Pankow, W. and Schuermann, M. (2000) Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J. Clin. Oncol., 18, 3221-3229.
39. Grote, H. J., Schmiemann, V., Geddert, H., Rohr, U. P., Kappes, R., Gabbert, H. E. and Böcking, A. (2005) Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int. J. Cancer, 116, 720-725. (Pubitemid 41099703)
40. Kim, Y. T., Lee, S. H., Sung, S. W. and Kim, J. H. (2005) Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Ann. Thorac. Surg., 79, 1180-1188. (Pubitemid 40431836)
41. Damiani, L. A., Yingling, C. M., Leng, S., Romo, P. E., Nakamura, J. and Belinsky, S. A. (2008) Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res., 68, 9005-9014.
42. O'Hagan, H. M., Mohammad, H. P. and Baylin, S. B. (2008) Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet., 4, e1000155. 10.1371/journal.pgen.1000155.